“…The photothermal conversion efficiency of hybrid ICG@GC-PP NPs at 808 nm as obtained from Figure S7, Supporting Information, is calculated to be 46.1%, which is similar to ICG-polydopamine nanodiamonds (44.5%), [41] but outperforms those of PEGylated PP (34.6%), [2a] iodinated PP (25.5%), [37a] cyanine dyes (26.6%), [42] Au@Fe 3 O 4 @PP (23.9%), [43] Au NRs (21%), and Au nanoshells (13%). [44] As ICG is one of the FDA-approved dyes for clinical use, [9] it was therefore envisaged that the biocompatibility track records of GC, PP, and ICG, would endow the proposed hybrid ICG@GC-PP nanosystem with appreciable tissue tolerance. In order to probe the in vitro toxicity of the photothermal agents, MTT assay was carried out by co-incubating various concentrations of free ICG, GC-PP, and ICG@GC-PP NPs, with mouse breast cancer (4T1) and human esophageal cancer (KYSE-30) cell lines for 24 h. As a consequence of the excellent biocompatibilities of the individual component polymers of GC-PP matrix, the high cell viability of ICG is not compromised by its loading in the dual-nanopolymer matrix.…”